GlaxoSmithKline Current Ratio 2006-2019 | GSK

Current and historical current ratio for GlaxoSmithKline (GSK) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. GlaxoSmithKline current ratio for the three months ending March 31, 2019 was 0.72.
GlaxoSmithKline Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $22.83B $31.86B 0.72
2018-12-31 $22.59B $30.02B 0.75
2018-09-30 $22.70B $23.97B 0.95
2018-06-30 $23.20B $24.77B 0.94
2018-03-31 $22.85B $37.47B 0.61
2017-12-31 $20.50B $34.24B 0.60
2017-09-30 $23.12B $35.92B 0.64
2017-06-30 $21.01B $36.81B 0.57
2017-03-31 $20.79B $23.23B 0.90
2016-12-31 $22.65B $25.75B 0.88
2016-09-30 $23.13B $23.82B 0.97
2016-06-30 $24.22B $25.98B 0.93
2016-03-31 $22.68B $19.94B 1.14
2015-12-31 $25.36B $20.52B 1.24
2015-09-30 $26.33B $19.77B 1.33
2015-06-30 $27.75B $21.13B 1.31
2015-03-31 $31.63B $23.93B 1.32
2014-12-31 $24.19B $21.91B 1.10
2014-09-30 $24.83B $25.52B 0.97
2014-06-30 $22.81B $20.62B 1.11
2014-03-31 $21.92B $19.31B 1.14
2013-12-31 $23.83B $21.40B 1.11
2013-09-30 $20.88B $19.89B 1.05
2013-06-30 $20.64B $19.17B 1.08
2013-03-31 $21.93B $18.66B 1.18
2012-12-31 $21.70B $21.90B 0.99
2012-09-30 $21.32B $22.06B 0.97
2012-06-30 $27.34B $24.39B 1.12
2012-03-31 $25.57B $22.83B 1.12
2011-12-31 $25.94B $24.08B 1.08
2011-09-30 $26.43B $21.13B 1.25
2011-06-30 $26.62B $22.23B 1.20
2011-03-31 $26.90B $20.99B 1.28
2010-12-31 $24.80B $19.51B 1.27
2010-09-30 $26.03B $17.42B 1.49
2010-06-30 $25.48B $17.91B 1.42
2010-03-31 $28.66B $18.98B 1.51
2009-12-31 $27.51B $18.98B 1.45
2009-09-30 $28.47B $18.26B 1.56
2009-06-30 $23.61B $13.99B 1.69
2009-03-31 $24.40B $14.02B 1.74
2008-12-31 $32.03B $18.58B 1.72
2008-09-30 $28.37B $16.69B 1.70
2008-06-30 $28.95B $16.30B 1.78
2008-03-31 $24.94B $18.47B 1.35
2007-12-31 $27.27B $20.70B 1.32
2007-09-30 $23.00B $18.25B 1.26
2007-06-30 $21.78B $14.31B 1.52
2007-03-31 $14.22B $9.75B 1.46
2006-12-31 $20.26B $13.39B 1.51
2006-09-30 $22.30B $13.67B 1.63
2006-06-30 $23.12B $15.07B 1.53
2006-03-31 $24.44B $16.38B 1.49
2005-12-31 $24.00B $17.32B 1.39
2005-09-30 $23.86B $15.96B 1.50
2005-06-30 $22.79B $15.66B 1.46
2005-03-31 $21.51B $17.76B 1.21
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $99.199B $41.140B
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $375.043B 17.01
Pfizer (PFE) United States $249.544B 13.61
Merck (MRK) United States $218.445B 17.97
Novartis AG (NVS) Switzerland $195.056B 16.85
AbbVie (ABBV) United States $119.967B 9.92
Novo Nordisk (NVO) Denmark $118.218B 19.67
Eli Lilly (LLY) United States $113.403B 21.05
Sanofi (SNY) France $105.120B 12.96
AstraZeneca (AZN) United Kingdom $97.922B 11.27
Bristol-Myers Squibb (BMY) United States $77.369B 11.43